Beauty Tech Group stock up as FY26 profit floor outpaces sales growth

Beauty Tech Group stock up as FY26 profit floor outpaces sales growth

July 7, 2026

London, July 7, 2026, 17:03 (BST)

  • Beauty Tech raised its FY26 revenue guidance floor to £170 million and now sees adjusted EBITDA at least £45 million. That puts the profit floor 8.4% above the company’s earlier consensus and the sales floor 5.1% higher.
  • Stock traded at 355p, higher by 22p, or 6.61%, as of 17:03 BST. Volume stood at 835,590 shares, worth around £3.0 million at that price.
  • Berenberg lifted its price target to 550p from 500p and maintained its buy rating, calling this the fourth upgrade to guidance since the company listed in October.
  • The main London session was done before the dateline. The London Stock Exchange trades from 0800 to 1630 BST.

The Beauty Tech Group Plc (LON:TBTG) told investors Tuesday profit will outpace sales in its latest upgrade. The at-home beauty device company said first-half sales came in well ahead of last year, and now sees 2026 revenue and adjusted EBITDA at least £170 million and £45 million.

The company had guided the market to expect £161.7 million revenue and £41.5 million in adjusted EBITDA before the update. The new minimum lifts revenue guidance by £8.3 million and adds £3.5 million to the adjusted EBITDA figure. That moves the margin floor up to 26.5%, compared with 25.7% in the previous consensus.

FY26 measurePrior company-compiled expectationsNew company floorChange
Revenue£161.7 mln£170.0 mlnup £8.3 mln / up 5.1%
Adjusted EBITDA£41.5 mln£45.0 mlnup £3.5 mln / up 8.4%
Implied adjusted EBITDA margin25.7%26.5%up 0.8 percentage point

The stock changed hands at 355p after moving in a range of 353.02p to 370p. That was a bigger rise than the market. The FTSE All-Share added 0.32% at 16:00 BST. The FTSE 250 slipped 0.44% on delayed data.

July 7 market moveLast/levelChangeTime basis
Beauty Tech Group355pup 6.61%17:03 BST
FTSE All-Share5,739.71up 0.32%16:00 BST
FTSE 25023,401.73down 0.44%delayed

Chief Executive Laurence Newman linked the upgrade to “significant growth across our core business” and said there are “product launches in the pipeline.” The company didn’t release a first-half revenue number in Tuesday’s statement. Interim results for the six months to June 30 are due out in September. Investegate

Berenberg moved its price target up to 550p from 500p, sticking with a buy call. That new target is about 55% higher than the most recent price at 355p.

Beauty Tech was already coming off a high-margin base before Tuesday. The group posted 2025 revenue of £141.0 million, adjusted EBITDA of £37.5 million, with a margin of 26.6%. Net cash was £40.8 million at year-end, swinging from net debt of £27.1 million the previous year.

FY25 baseFY25FY24Change
Revenue£141.0 mln£101.1 mln+39.4%
Adjusted EBITDA£37.5 mln£22.9 mln+63.8%
Adjusted EBITDA margin26.6%22.6%up 4 points
Net cash/(debt)£40.8 mln£(27.1) mlnn/a

The new £170 million revenue floor implies about 20.6% growth over the base for 2026. Adjusted EBITDA floor of £45 million implies 20.0% growth. Margin floor is mostly unchanged from FY25’s 26.6%, so the September update will show how much is down to product launch costs versus gross margin.

Liquidity hasn’t really changed. Back in May, pre-IPO holders wanted to sell as many as 8.8 million shares—roughly 7.9% of the total—in a secondary offer to raise the free float and bump up trading. Only 835,590 shares traded on Tuesday, less than a tenth of that original block.

Beauty Tech shares trade at 355p, up roughly 31% from their 271p IPO price. The company listed in October at a near £300 million valuation, raising around £29 million in new capital. Beauty Tech said the cash would clear its debts and support working capital.

September is the next date to watch. Tuesday’s RNS said interim results will land then, but the market still doesn’t know what the first-half sales number or half-year margin are.

Mateusz Brzeziński

Mateusz Brzeziński is a financial and technology journalist at Bez-kabli.pl, covering stocks, artificial intelligence, semiconductors and global market developments. He graduated from the Prague University of Economics and Business in the Czech Republic and previously worked in financial analysis before moving into business journalism. His reporting focuses on the companies, technologies and market trends shaping the global economy.

Stock Market Today

  • Reckitt Benckiser (LSE: RKT) up 15% in a month, still lagging on value
    July 7, 2026, 12:23 PM EDT. Shares of Reckitt Benckiser (LSE: RKT) have jumped 15% over the last month, beating the FTSE 100, which rose 3%. The stock is trading at 11 times earnings with a 4.1% dividend yield. Even after the rally, shares are still 16% below where they started the year. Reckitt, behind brands like Dettol and Nurofen, has had to deal with big write-downs from its 2017 acquisition and ongoing litigation risks, but the company has a track record of generating solid profits and free cash flow to pay its dividend. Investors are weighing the stock's long-term prospects as market uncertainty lingers over tariffs and geopolitical tensions.